Status:
ACTIVE_NOT_RECRUITING
Long-term Outcomes of Early-stage Nasopharyngeal Carcinoma Patients Treated with Radiotherapy Alone
Lead Sponsor:
Taichung Veterans General Hospital
Conditions:
Nasopharyngeal Carcinoma (NPC)
Oncology
Eligibility:
All Genders
20+ years
Brief Summary
Nasopharyngeal carcinoma (NPC) is a malignant tumor primarily originating in the nasopharynx, commonly found in populations in southern China, certain regions of Asia, and North Africa. The main treat...
Eligibility Criteria
Inclusion
- Diagnosed with nasopharyngeal carcinoma based on endoscopic pathological reports.
- Included early-stage patients classified as cT1-2, cN0-1, M0.
- Had baseline imaging (CT or MRI) prior to treatment.
- Received definitive radiotherapy at our institution and had long-term follow-up with complete medical records.
Exclusion
- Excluded from the study are patients with local lymph node metastasis or distant metastasis (cN ≥ 2, M = 1) as determined by imaging studies.
- Patients who did not receive definitive radiotherapy at our institution or had incomplete medical records during long-term follow-up are also excluded.
- Patients diagnosed with any other primary cancer within five years prior to the diagnosis of nasopharyngeal carcinoma (excluding DCIS and skin cancer) are excluded from the study.
Key Trial Info
Start Date :
October 2 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2025
Estimated Enrollment :
262 Patients enrolled
Trial Details
Trial ID
NCT06612697
Start Date
October 2 2023
End Date
September 1 2025
Last Update
September 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taichung Veterans General Hospital
Taichung, Taiwan